Abstract
Meta-analyses of cohort studies and a recent randomized, placebo-controlled study have shown that perioperative bridging of warfarin therapy with therapeutic doses of heparin results in a multi-fold increase in major bleeding but no reduction in the incidence of thromboembolism. It is time to reconsider heparin bridging: When is heparin bridging superfluous? When is prophylactic dosage indicated? And when is it safe to use therapeutic dosing?
| Bidragets oversatte titel | Perioperative heparin bridging is rarely indicated |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 178 |
| Udgave nummer | 9 |
| Sider (fra-til) | V12150952 |
| ISSN | 0041-5782 |
| Status | Udgivet - 29 feb. 2016 |
Emneord
- Anticoagulants/administration & dosage
- Hemorrhage/chemically induced
- Heparin/administration & dosage
- Heparin, Low-Molecular-Weight/administration & dosage
- Humans
- Perioperative Care
- Thromboembolism/prevention & control
- Vitamin K/antagonists & inhibitors
- Warfarin/administration & dosage
Fingeraftryk
Dyk ned i forskningsemnerne om 'Perioperativ heparin-bridging er sjældent indiceret'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS